Literature DB >> 12055389

Neuroendocrine tumors of the lung: recent developments in histopathology.

Douglas B Flieder1.   

Abstract

Lung tumors with neuroendocrine differentiation are made up of several neoplasms with particular epidemiologic, clinical, morphologic, and molecular characteristics. Typical and atypical carcinoid tumors represent low-grade and intermediate-grade carcinomas, respectively, whereas small-cell carcinoma and large-cell neuroendocrine carcinoma are considered high-grade carcinomas. Recent studies support the use of this four-tumor, three-tier classification scheme, but in practice, definitive diagnoses on small tissue samples remain a challenge for even the most experienced lung pathologists.

Entities:  

Mesh:

Year:  2002        PMID: 12055389     DOI: 10.1097/00063198-200207000-00006

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

1.  Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung.

Authors:  Guida Maria Portela-Gomes; Lars Grimelius; Mats Stridsberg; Enrica Bresaola; Giuseppe Viale; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2005-05-20       Impact factor: 4.064

2.  Morphologic analysis of pulmonary neuroendocrine tumors.

Authors:  Seung Seok Lee; Myunghee Kang; Seung Yeon Ha; Jungsuk An; Mee Sook Roh; Chang Won Ha; Jungho Han
Journal:  Korean J Pathol       Date:  2013-02-25

3.  Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours.

Authors:  Fabian Dominik Mairinger; Robert Fred Henry Walter; Dirk Theegarten; Thomas Hager; Claudia Vollbrecht; Daniel Christian Christoph; Karl Worm; Saskia Ting; Robert Werner; Georgios Stamatis; Thomas Mairinger; Hideo Baba; Konstantinos Zarogoulidis; Haidong Huang; Qiang Li; Kosmas Tsakiridis; Paul Zarogoulidis; Kurt Werner Schmid; Jeremias Wohlschlaeger
Journal:  J Cancer       Date:  2014-08-01       Impact factor: 4.207

4.  Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.

Authors:  Paul Gozzard; Caroline Chapman; Angela Vincent; Bethan Lang; Paul Maddison
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.